Your browser doesn't support javascript.
loading
A Promising New Anti-Cancer Strategy: Iron Chelators Targeting CSCs.
Chen, Yuehua; Ohara, Toshiaki; Xing, Boyi; Qi, Jiping; Noma, Kazuhiro; Matsukawa, Akihiro.
Affiliation
  • Chen Y; Department of Pathology and Experimental Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
  • Ohara T; Department of Pathology, the First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Xing B; Department of Pathology and Experimental Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
  • Qi J; Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
  • Noma K; Department of Pathology and Experimental Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
  • Matsukawa A; Department of Pathology, the First Affiliated Hospital of Harbin Medical University, Harbin, China.
Acta Med Okayama ; 74(1): 1-6, 2020 Feb.
Article in En | MEDLINE | ID: mdl-32099242

Full text: 1 Database: MEDLINE Main subject: Iron Chelating Agents / Iron / Neoplasms / Antineoplastic Agents Limits: Humans Language: En Year: 2020 Type: Article

Full text: 1 Database: MEDLINE Main subject: Iron Chelating Agents / Iron / Neoplasms / Antineoplastic Agents Limits: Humans Language: En Year: 2020 Type: Article